IDEXX Labs (NASDAQ: IDXX) reported Q3 EPS of $2.03, $0.13 better than the analyst estimate of $1.90. Revenue for the quarter came in at $810 million versus the consensus estimate of $798.16 million.

GUIDANCE:

IDEXX Labs sees FY2021 EPS of $8.30-$8.38, versus the consensus of $8.38. IDEXX Labs sees FY2021 revenue of $3.185-3.2 billion, versus the consensus of $3.2 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.